P henotypic modulation of vascular smooth muscle cells (VSMC 1 ) is critical during development and in the onset of diseases such as atherosclerosis and hypertension. Atherosclerosis is a leading cause of heart disease and stroke and causes Ϸ50% of all deaths. 2, 3 Therefore, understanding the physiology of large vessels will help to identify the cause of a primary cardiovascular disease. VSMC in mature animals express multiple contractile proteins to maintain vascular tone. These proteins are markers for the differentiated contractile phenotype. Unlike myocardial and skeletal muscle cells, VSMC are highly plastic and retain the ability to modulate their phenotype. 4 -6 Environmental factors can alter the expression levels of these contractile proteins, leading to a switch from a differentiated phenotype, characterized by high expression, to a proliferative, dedifferentiated phenotype characterized by low expression. This occurs in pathophysiologic states of large arteries such as atherosclerosis, where migration and proliferation of neointimal VSMC lead to vascular remodeling. 7, 8 In adult cultured VSMC, vasoconstrictors, such as angiotensin II or arginine vasopressin (AVP), increase expression of smooth muscle (SM) markers such as SMA and SM22␣, whereas growth factors such as platelet derived growth factor (PDGF) decrease protein and mRNA levels of these proteins. 1,9 -11 We have shown that these effects are mediated through transcriptional regulation of SM specific promoter activity, and have defined specific signal transduction pathways that regulate SM specific gene expression by AVP or PDGF. AVP-induced increases in gene expression require c-jun amino terminal kinase and p38 MAP kinases, whereas PDGF-induced suppression is mediated by Ras, and phosphatidylinositol 3-kinase (PI3K)/Akt pathways. 1, [11] [12] [13] The promoters of these SM-genes contain common regulatory elements, specifically multiple CArG boxes, which have been shown to bind the MCM1, agamous, deficiens, serum response factor (MADS) box transcription factor, serum response factor (SRF). 14, 15 Many SM-genes contain multiple CArG boxes in the proximal region of their promoter. Truncations, deletions, or point mutations in individual CArG elements of the SMA and SM22␣ promoters abolish both basal and AVP stimulated activation. 12, 16 Single copies of these CArG elements are also found in the promoters of a number of immediate early genes (IEG) such as c-fos. 17, 18 Selective regulation of SM-specific genes vis-à-vis IEG is mediated through specific associations of SRF with distinct families of coactivators. We have recently demonstrated that activation of the PI3K/Akt pathway by PDGF mediated down regulation of SM specific gene expression in part through relocalization of SRF to an extranuclear compartment. 1 This would effectively reduce the amount of SRF that is available to bind to the promoters of SRF-dependent genes. Changes in actin dynamics regulate the transcriptional activity of SRFdependent genes in several muscle types, 19, 20 and nonmuscle cells. 21 Redistribution of SRF from the nucleus to the cytosol through changes in actin dynamics [22] [23] [24] [25] and by reduced Rho activity 26 suggests that reduced SRF-dependent transcription may correlate with redistribution of the nucleus. 20, 27 As an alternative way to inhibit SRF transactivation, and define the effects of blocking activation by this transcription factor, we have used an RNAi approach in cultured VSMC. The results from this study indicate that depletion of SRF not only suppresses expression of SM markers, but unexpectedly has broader effects in controlling the proliferation and migration of these cells. This study also places SRF as a potential regulatory node in events occurring during neointima formation.
Materials and Methods
Rat aortic VSMC were isolated and cultured as previously described. 12 Two sequences selected from different regions of the human SRF (Ac#J03161) coding sequence; Sequence A (human 648 to 669 cds): 5Ј-GACCTGCCTCAACTCGCCAGAC and Sequence B (human 1207 to 1228 cds): 5Ј-GTGGGTGGCCACATGATGTACC were used to construct corresponding hairpin SRF-RNAi sequences driven by U6 promoter (shRNAi; GenScript), which were then used in transient and stable transfection. For stable transfections, VSMC were transfected with 0.5 g of SRF RNAi plasmids or control plasmid and grown in media containing 500 g/mL G418 to select stable transfectants, and individual clones were picked. For transient transfections measuring promoter activity, a sequence encoding 765-bp of the rat SM-␣-actin promoter coupled to luciferase together with cytomegalovirus-␤-galactosidase vector (CLONTECH) were used. The transfections also included 0.05 g of SRF RNAi plasmids or control plasmid. Cell lysates were assayed for luciferase and ␤-galactosidase activities as previously described. 12 Proliferation assays were preformed by 3 H-Thymidine incorporation. For add-back experiments, proliferation of cells transiently transfected with Green Fluorescent Protein (GFP) and SRF was determined by counting green cells. Migration of VSMC was measured using 5% serum in the bottom chamber of a Transwell chamber. The number of nuclei on the bottom of the Transwell membrane were stained with DAPI and counted. Change in mRNA levels was measured by Quantitative Real-Time PCR. Percent change in the arbitrary copy numbers normalized to Ribosomal RNA was used.
Results
Previously we demonstrated that PDGF-mediated activation of the PI3K/Akt pathway decreases nuclear levels of SRF as a result of accumulation in a cytosolic compartment. We proposed that this mechanism accounts, at least in part, for the ability of PDGF to decrease basal, and AVP-induced activation of SM-genes. 1 To determine whether ablation of SRF would have similar effects, 2 sequences specific for SRF were designed and inserted into a plasmid driven by U6 promoter (shRNAi). VSMC were transiently cotransfected with these SRF shRNAi constructs along with a promoter/ reporter construct for SMA. 16 Cells transfected with SRF shRNAi had reduced basal promoter activity, and AVP stimulation of the promoter was abolished, compared with cells cotransfected with an empty vector ( Figure 1A) or a plasmid encoding an irrelevant shRNAi (data not shown). To confirm that the effects of the SRF RNAi sequences were attributable to depletion of SRF in rat VSMC, stable transfectants were selected by G418 resistance. Figure 1B shows western blotting with SRF and SMA antibodies of 6 indepen- Figure 1 . SRF depletion suppresses SMA promoter activity and protein levels. A, VSMC were transiently transfected with SMA promoter coupled to Luciferase reporter as described in the online supplement available at http://circres.ahajournals. org. Cells were stimulated with AVP (10 Ϫ6 mol/L) or the vehicle (Basal) for 72 hours in the presence of plasmids containing either 2 different RNAi sequences (Seq A or B) or control plasmid. Promoter activity normalized to ␤-galactosidase was determined. Results represent the mean and SEM of 3 experiments performed in duplicate, percent change over basal stimulation is shown. *PϽ0.05 vs Basal in pU6.1/Neo, #PϽ0.05 vs AVP in pU6.1/Neo. B, VSMC stably expressing Sequence B shRNAi were serum-restricted for 24 hours and extracts were immunoblotted with SRF, SMA, or total actin. C, VSMC stably expressing Sequence B shRNAi were transiently transfected with the indicated amounts of an expression plasmid encoding SRF, along with the SMA promoter construct, and luciferase activity normalized to ␤-gal determined as indicated above. Results represent the mean and SEM of 3 experiments performed in duplicate, percent change over pU6.1/Neo#1 is shown. *PϽ0.05 vs pU6.1/ Neo#1, #PϽ0.05 vs SRF shRNAi#6 in basal condition. dent clones transfected with Sequence B-SRF shRNAi compared with 2 independent clones transfected with control plasmid. Total actin levels were blotted as loading control. Expression levels of SRF were reduced in all 6 SRF RNAi clones selected. All of the clones also had reduced expression of SMA. Sequence B-Clone #3 had the highest SRF expression levels among the SRF shRNAi clones, and also had higher SMA levels. Sequence B-Clone #2 and Clone #6, which had the lowest SRF expression levels, were chosen for further analysis. To confirm that the decrease in SMA promoter activity was directly attributable to loss of SRF expression, cells expressing SRF RNAi were transiently transfected with an expression plasmid encoding SRF. As shown in Figure 1C , reexpression of SRF restored basal SMA promoter activity in a dose-dependent manner.
In addition to SMA, and SM22␣, depletion of SRF also reduced the expression of 2 SRF-dependent immediate early genes, c-Fos, and Egr-1 ( Figure 2A ). Levels of mRNA expression of the smooth and cardiac muscle-specific SRF coactivator, myocardin, a CArG containing gene 14 were also reduced ( Figure 2B ). However, there was no significant change in the expression of Elk-1 ( Figure 2A ), which has been shown to be involved in induction of c-fos by growth factors. 28 On the other hand, the expression level of c-jun was unexpectedly increased to levels comparable to those achieved with PDGF stimulation of control cells ( Figure 2A ). These data suggested that ablation of SRF may effect expression of other genes, not directly containing SRF binding sites, and could mimic the biological responses of VSMC to PDGF. We therefore examined the effects of SRF ablation on 2 responses of VSMC to PDGF: proliferation and migration. Proliferation, of SRF depleted clones #2 and #6, was measured by 3 H-Thymidine incorporation. Cells with depleted SRF levels (SRF shRNAi #2, and #6) had higher proliferative rates under low-serum conditions, and in response to PDGF-BB (20 ng/mL) stimulation compared with control cells ( Figure 2C ). However, proliferative rates in response to serum (10%) stimulation were not affected by depletion of SRF. This was confirmed by changes in cell number. Control cells doubled in number (from 20 000 cells to 48 000 cells) after 48 hours; however SRF depleted cells showed 4 to 5 fold increases (from 22 000 cells to 104 000 cells) in cell number. Examination of stable pools of Embryonic day 17 (E17) rat VSMC also showed similar increases in proliferation after SRF depletion (data not shown), despite their nonproliferative responsiveness to PDGF-BB. 29 To confirm that the increase in proliferation was directly attributable to loss of SRF expression, cells expressing SRF RNAi were transiently cotransfected with expression plasmids encoding SRF or empty vector and GFP. As shown in Figure 2D , numbers of GFP expressing cells were higher in SRF depleted cells, and reexpression of SRF reduced the number of GFP expressing cells to levels seen in control cells. To assess affects on migration, Transwell assays were used, with cells exposed to 5% serum in the bottom chamber. SRF depleted clones had dramatically higher number of migrating cells compared with the control cells (pU6.1/Neo #1 and #2) ( Figure 2E ).
To confirm that these effects were not a result of alterations in signaling through PDGF receptors, expression levels of PDGF receptor ␤ (PDGFR␤) and its activation by PDGF were measured by Western blotting with antibodies against total and phospho-receptor. As shown in Figure 3A , there was no difference in expression of PDGFR␤ between SRF depleted and control cells, and stimulation for 5 minutes with PDGF resulted in equivalent levels of phospho-receptor. Stimulation of VSMC for 6 hours with PDGF-BB resulted in downregulation of PDGFR␤ expression, and this occurred to the same extent in SRF-depleted and control cells ( Figure  3A) . Finally, Akt, a downstream effector of PDGF receptor signaling, was activated to similar levels in SRF depleted clones compared with control cells (Figure 3B) .
Based on the gene array analysis, 30 PDGF-BB increased the mRNA expression of a condroidin sulfate proteoglycan, Versican, and a cytokine, Gro, but decreased the expression of Collagen X 1␣. Quantitative Real-Time PCR (Q-RT-PCR) analysis showed that VSMC depleted of SRF (SRF shRNAi Clones #2, and #6) also had marked increases in mRNA levels for Versican when compared with control cells (U6.1/ Neo clones #1 and #2). However, mRNA levels of Gro and ColX1␣ were not significantly changed ( Figure 4A ). We have also shown that PDGF-BB increases the protein expression of C/EBP␦, Ezrin, GADD45␣, and hemeoxygenase 1 (HmOx-1), and decreases the protein expression of Nexilin. 30 Western analysis of samples from VSMC depleted of SRF (SRF shRNAi #2 and #6) and control cells (pU6.1/Neo #1 and #2) showed that C/EBP␦, Ezrin, GADD45␣, and HmOx-1 expression levels were also increased in SRF depleted cells. Conversely, protein expression of Nexilin was dramatically decreased in SRF depleted clones ( Figure 4B ). Similarly, in SRF RNAi-treated E17 VSMC, a reduced SRF, and consequently a reduced SMA expression level was accompanied by increased C/EBP␦ protein expression levels (data not shown).
Discussion
SRF is a MADS box transcription factor, which is critical in the regulation of muscle growth and development. It binds to specific cis-regulatory elements, namely CArG boxes, of muscle specific genes, and IEG. Mutations in the CArG boxes of SM-specific genes inhibit expression of SM-markers during development, 5, 6, 14 and regulation by hormonal factors in cultured VSMC. 12, 13, 31, 32 Phenotypic remodeling in mature vessels is regulated by local environmental cues including humoral factors, cell-cell and cell-matrix interactions, mechanical stresses, and inflammatory stimuli. Our laboratory has observed the convergence of signaling from both differentiating and dedifferentiating signals on SRF transactivation. PDGF induces a variety of cellular responses in VSMC including cell proliferation, migration, dedifferentiation, and extracellular matrix deposition. Previously we have shown that PDGF-mediated suppression of SM-specific gene expression is mediated through an Akt-dependent pathway that leads to partial redistribution of SRF to a cytoplasmic location. 1 This, redistribution effectively decreases the concentration of SRF within the nucleus. Decreases in nuclear SRF levels will presumably lead to decreased binding to specific CArG boxes, and suppression of expression of SRF-dependent genes. In this study we have more directly examined the biological consequences of decreasing SRF
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expression through RNAi. Our data show that ablation of SRF results in inhibition of both SM-specific genes and IEG expression. However, to our surprise, SRF depletion mimicked the biological responses of these cells to PDGF stimulation in adult VSMC. Previously, SRF has been shown to be dispensable for ES cell proliferation and cell cycle regulation, 33 and required for ES cell migration. 34 Surprisingly, in addition to inhibition of SM-specific gene expression, SRF depletion increased VSMC proliferation and migration ( Figure  2 ), both effects seen with PDGF. Reexpression of SRF reversed the effects of SRF depletion on both muscle gene expression and proliferation, indicating that they are not a result of nonspecific effects of siRNA. VSMC prolifera- tion and migration are the key elements in development of the blood vessels, as well as in the formation of neointima during vascular injury. 35, 36 Induction of c-jun by PDGF-BB is important for VSMC proliferation during vascular injury, [37] [38] [39] as well as in the promotion of the migratory phenotype of VSMC. 40 In our cells, depletion of SRF by shRNAi resulted in increases in basal c-jun expression to levels achieved by PDGF stimulation of control cells (Figure 2A ). This suggests that SRF acts to suppress c-jun expression, and that this suppression is relieved by PDGF stimulation. On the other hand, because PDGF was further able to increase c-jun expression in SRF depleted cells, likely that PDGF mediates induction of c-Jun through SRF-independent mechanisms as well. Sandbo et al 41 reported that increased c-jun expression coincided with reduced SRF transactivation. However, these workers concluded the inhibition of SRF transactivation was mediated by increased c-jun expression, 41 placing c-jun upstream of SRF. Our data suggest that in our cells SRF is proximal to regulation of c-jun expression.
In addition to c-jun expression, the expression levels of several, but not all PDGF-regulated genes were also changed in response to SRF depletion. Expression of growth arrest and DNA damage induced-45 (GADD45)␣, which is associated with proliferation, was increased in cells expressing SRF RNAi. HmOx-1 is an antioxidant and antiinflammatory enzyme, which is increased during vascular injury as a feed-back response. 42 Similar to PDGF stimulation, 30 SRF depletion also increased HmOx-1.
SRF depletion increased the expression of a PDGF inducible transcription factor CCAAT-enhanced binding protein delta (C/EBP␦). 30 C/EBP␦ overexpression was correlated with increased PDGF␣R, and vascular remodeling, 43 and in our studies correlated with decreased SM-specific gene expression, and neointima formation. 30 In addition, the expression level of Versican (CSPG2), an extracellular matrix proteoglycan, was upregulated in SRF depleted cells. We have previously shown that versican is upregulated by PDGF stimulation. 30 Versican is secreted by VSMC in normal blood vessels, and is also a marker of atherosclerosis and vascular injury. 44 -46 Nexilin, an F-actin binding protein localized to cell-matrix junctions 47 was downregulated, and Ezrin, which has metastatic properties 48, 49 was upregulated in SRF depleted VSMC. Both of these effects were seen with PDGF. Expression of nexilin is increased by hypertrophic stimuli, and decreased expression is seen during neointima formation. 30 The regulatory regions of these genes are of interest; however the promoter regions have not been well defined for many of them. In fact, the promoter region of Versican has several C/EBP binding elements. 30 Depletion of SRF increases expression of several growth related genes, including GADD45, c-Jun, Versican, which in combination may have effects on the growth properties of these cells. SRF-mediated changes in expression of a tran- 
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scription factor like C/EBP␦ will lead to secondary changes in expression of genes that lack CArG boxes and SRF binding sites. Regulation of cell-matrix interactions might also play a major role in the migration, differentiation, and proliferation of VSMC, and SRF transcriptional activity might play a key role in keeping the balance between differentiated and dedifferentiated, migratory phenotype of VSMC. The effects of SRF depletion were not attributable to altered signaling through the PDGFR-␤. Levels of PDGFR␤ expression, activation and desensitization by PDGF, and activation of the downstream effector Akt, were not altered in VSMC depleted of SRF. In addition, PDGF was still able to increase c-jun expression in SRF depleted cells, suggesting an intact signaling pathway.
Developmental studies of SRF depletion have shown that targeted deletion of SRF is embryo lethal at e11.5 to 13.5 attributable to impairment in the development of cardiovascular system 50, 51 or attributable to skeletal hypoplasia. 52 However, the role of SRF in modulating the phenotype of adult cells has not been clearly defined. Based on our data, we would propose that regulation of SRF transcriptional activity is central to the biological response of VSMC, beyond controlling expression of genes containing known CArG elements in their promoter. In fact, the pleiotropic response of VSMC to PDGF, ie, dedifferentiation, proliferation, extracellular matrix deposition, and migration, may require inactivation of SRF. These effects could occur through redistribution of the protein of the nucleus, as we have previously shown. 1 In fact, SRF transactivation is decreased in smooth muscle tumors. 53 Posttranlational modifications of SRF might be important in regulation of SRF transcriptional activity. Several studies have shown that SRF can be phosphorylated on several residues. 12,54 -57 Interestingly, loss of SRF binding in aging fibroblasts has been associated with hyperphosphorylation of SRF. 58 Further studies on the relationship between SRF phosphorylation, subcellular distribution and transcriptional activity are required. Finally, because our data suggest that SRF dependent pathways mediate the effects of PDGF, including proliferation, migration, extracellular matrix deposition, and dedifferentiation, targeting the signaling pathways leading to SRF transcriptional inactivation may present a novel strategy in treatment of phenotypic modulation of VSMC associated with vessel injury and formation of atherosclerotic lesions. For stable transfections, VSMC were transfected with 0.5 µg of SRF RNAi plasmids or control plasmid per 100mm dish as described above. Cells were then grown in media containing 500µg/ml G418 to select for stable transfectants, and individual clones expanded after sequential dilutions and ring cloning. A minimum of 12 clones were picked, and western blotting with an SRF antibody was used to characterize the clones. were serum restricted in 0.2%-FCS-EMEM, and then stimulated with PDGF or 10% serum for 24hr. 3 H-Thymidine (1mCi/ml) was added to the media for the last 6 hours of the incubation. Cells were rinsed extensively on ice with ice-cold PBS to remove free 3 HThymidine, and then precipitated with 10% (w/v) trichloroacetic acid (TCA) for 30min on ice. The cells were then rinsed with 10% TCA, followed by three washes with 95%
ice-cold ethanol. Ethanol was removed and samples were air-dried on ice. 
